To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

Clinical trial NCT02626689 · COMPLETED

Trial details

NCT number: NCT02626689
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Beta-Thalassemia

Start date: 2016-03-01
Primary completion: 2017-01-03
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.